CA2165459A1 - Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2yl)-1h- imidazole - Google Patents

Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2yl)-1h- imidazole

Info

Publication number
CA2165459A1
CA2165459A1 CA002165459A CA2165459A CA2165459A1 CA 2165459 A1 CA2165459 A1 CA 2165459A1 CA 002165459 A CA002165459 A CA 002165459A CA 2165459 A CA2165459 A CA 2165459A CA 2165459 A1 CA2165459 A1 CA 2165459A1
Authority
CA
Canada
Prior art keywords
inden
dihydro
imidazole
fluoro
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002165459A
Other languages
English (en)
French (fr)
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Seppo Sulevi Lennart Parhi
Maire Marjatta Eloranta
Antti Sakari Haapalinna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2165459A1 publication Critical patent/CA2165459A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002165459A 1993-06-18 1994-06-16 Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2yl)-1h- imidazole Abandoned CA2165459A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9312669.6 1993-06-18
GB939312669A GB9312669D0 (en) 1993-06-18 1993-06-18 New opticla isomers

Publications (1)

Publication Number Publication Date
CA2165459A1 true CA2165459A1 (en) 1995-01-05

Family

ID=10737432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002165459A Abandoned CA2165459A1 (en) 1993-06-18 1994-06-16 Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2yl)-1h- imidazole

Country Status (19)

Country Link
EP (1) EP0703903A1 (no)
JP (1) JPH08511554A (no)
CN (1) CN1125439A (no)
AU (1) AU6972594A (no)
BG (1) BG100218A (no)
CA (1) CA2165459A1 (no)
CZ (1) CZ332195A3 (no)
EE (1) EE9400010A (no)
GB (1) GB9312669D0 (no)
HU (1) HU211271A9 (no)
IL (1) IL109984A0 (no)
LT (1) LT3468B (no)
LV (1) LV11462B (no)
NO (1) NO955056D0 (no)
NZ (1) NZ267427A (no)
PL (1) PL312194A1 (no)
SK (1) SK157095A3 (no)
WO (1) WO1995000492A1 (no)
ZA (1) ZA944346B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB2225782A (en) 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
ZA944346B (en) 1995-02-15
EP0703903A1 (en) 1996-04-03
NO955056L (no) 1995-12-13
AU6972594A (en) 1995-01-17
NO955056D0 (no) 1995-12-13
BG100218A (bg) 1996-06-28
LV11462B (en) 1996-12-20
CZ332195A3 (en) 1996-05-15
IL109984A0 (en) 1994-12-29
EE9400010A (et) 1995-12-15
PL312194A1 (en) 1996-04-01
LT3468B (en) 1995-10-25
GB9312669D0 (en) 1993-08-04
SK157095A3 (en) 1996-06-05
NZ267427A (en) 1996-10-28
LTIP1959A (en) 1995-01-31
JPH08511554A (ja) 1996-12-03
HU211271A9 (en) 1995-11-28
CN1125439A (zh) 1996-06-26
WO1995000492A1 (en) 1995-01-05
LV11462A (lv) 1996-08-20

Similar Documents

Publication Publication Date Title
CA1200241A (en) Pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydro- benzo¬g|quinoline derivatives
US5498623A (en) 4(5) substituted imidazoles and their preparation and use
FR2531707A1 (fr) Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
EP0031753B1 (fr) Nouveaux dérivés de la (pipéridyl-4)-2 (quinolyl-4)-1 éthanone, produits intermédiaires et procédés pour leur préparation, et leur utilisation comme médicaments
FR2659323A1 (fr) Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
JP2868813B2 (ja) 置換イミダゾール、その製造法およびそれを有効成分とするα２−受容体拮抗医薬組成物
WO1993020045A1 (fr) Derives d'indane-1,3-dione et d'indane-1,2,3-trione, leurs procedes de preparation et leur application en therapeutique
CA2165459A1 (en) Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2yl)-1h- imidazole
FI67544C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefullt imidazolinderivat
US4560696A (en) Analgesic, antipyretic or anti-inflammatory imidazole compounds
KR0139201B1 (ko) 아미노벤젠술폰산 유도체
EP0050072B1 (fr) Nouvelles cyclopropylméthyl pipérazines, leur procédé de préparation et leur application en thérapeutique
US5096929A (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them
NO173010B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt sulfonanilid
JP2003532712A (ja) α２アドレナリン作用活性を有する新規な多環式インダニルイミダゾール
US4707488A (en) Dopamine-β-hydroxylase inhibitors and use thereof
EP0322391B1 (en) New phenylalkylamine derivatives
US4992459A (en) Dopamine-β-hydroxylase inhibitors
FR2649395A1 (fr) Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
US5194450A (en) Anti-hypertensive sulfonanilides
US5137908A (en) 4-azahexacyclododecane compounds
US4360680A (en) Therapeutically active 3-amino-1-phenyl and substituted phenyl-2-pyrazolines
EP0103500A2 (fr) Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique
DK144299B (da) Analogifremgangsmaade til fremstilling af 1-fenyl2-amino-1,3-propandiol-n-alkyl-derivater eller fysiologisk acceptable salte deraf
US4810811A (en) Dopamine-beta-hydroxylase inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued